Product pipeline

Serodus has an extensive pipeline within diabetes and diabetic complications.

SER150

SER150 is a small molecule with anti-inflammatory properties.

SER150

SER150 is a small molecule with anti-inflammatory properties.

SER140

SER140 is a potent interleukin-1 (IL-1) receptor antagonist.

SER130

SER130 is a potent interleukin-4 (IL-4) agonist.

SER190

SER190 is an IL-1β receptor antagonist

Product

Discovery

Preclinical

Phase 1

Phase 2

SER150

Kidney Disease in T2D

SER150

Kidney Disease in T1D

SER140

Newly diagnosed T1D (preservation of the residual beta-cell function)

SER130

Diabetic Retinopathy in T1D & T2D

SER190

Diabetic Foot Ulcer